ASKLEPIOS BIOPHARMACEUTICAL
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders and other rare diseases. It offers proprietary AAV technology, manufacturing capabilities, and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry. Its pipeline includes clinical-stage programs in Pompe disease and congestive heart failure and a diverse preclinical portfolio of therapeutics targeting neuromuscular, C... NS, and other diseases, as well as out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The companyโs gene therapy platform includes Pro10, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid, and promoter library. Asklepios BioPharmaceutical was founded in 2001 and is headquartered in Research Triangle Park, North Carolina.
ASKLEPIOS BIOPHARMACEUTICAL
Industry:
Biopharma Biotechnology Health Care Manufacturing Medical Medical Device
Founded:
2001-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.askbio.com
Total Employee:
501+
Status:
Active
Contact:
+1 (919) 561-6210
Total Funding:
241.76 M USD
Technology used in webpage:
Person Schema Gravatar Profiles U.S. Server Location WP Engine Getty Images
Similar Organizations
Avinger
Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.
Bolt Threads
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
JenaValve Technology
JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions
Masimo
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products.
MediWound
MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
ResMed
A global leader in digital health and connected medical devices, plus software solutions that support out-of-hospital care providers.
SHINE Medical Technologies
SHINE Medical Technologies manufactures and supplies medical tracers and cancer treatment elements.
Vaxart
Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-04-22 | Brainvectis | Brainvectis acquired by Asklepios BioPharmaceutical | N/A |
2019-09-17 | RoverMed BioSciences | RoverMed BioSciences acquired by Asklepios BioPharmaceutical | N/A |
2019-08-13 | Synpromics Ltd | Synpromics Ltd acquired by Asklepios BioPharmaceutical | N/A |
Investors List
Scottish Enterprise
Scottish Enterprise investment in Grant - Asklepios BioPharmaceutical
Vida Ventures
Vida Ventures investment in Private Equity Round - Asklepios BioPharmaceutical
TPG Capital Asia
TPG Capital Asia investment in Private Equity Round - Asklepios BioPharmaceutical
Muscular Dystrophy Association
Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical
Muscular Dystrophy Association
Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical
Key Employee Changes
Date | New article |
---|---|
2024-04-09 | AskBio appoints new chief scientific officer |
Official Site Inspections
http://www.askbio.com Semrush global rank: 2.55 M Semrush visits lastest month: 7.23 K
- Host name: 172.99.75.43
- IP address: 172.99.75.43
- Location: San Antonio United States
- Latitude: 29.4963
- Longitude: -98.4004
- Metro Code: 641
- Timezone: America/Chicago
- Postal: 78218
More informations about "Asklepios BioPharmaceutical"
Ask Bio - a Gene Therapy Company in RTP, North โฆ
AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies. Research and development facilities are located in Philadelphia, Pennsylvania; Upper โฆSee details»
Asklepios BioPharmaceutical - Crunchbase Company โฆ
Organization. Asklepios BioPharmaceutical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Morningstar, Inc. โ AskBio Receives FDA Rare Pediatric Disease and โฆSee details»
AskBio Announces Gustavo Pesquin as New CEO
Mar 9, 2023 Research Triangle Park, N.C.โ March 9, 2023 โ Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become โฆSee details»
AskBio Announces Gustavo Pesquin as New CEO - Bayer
Mar 9, 2023 Itโs very energizing to join an organization with such purpose.โ About AskBio Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene โฆSee details»
Asklepios BioPharmaceutical, Inc. (AskBio) | LinkedIn
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving ...See details»
Asklepios BioPharmaceutical, Inc. (AskBio) | LinkedIn
Asklepios BioPharmaceutical, Inc. (AskBio) | 34,827 followers on LinkedIn. Pioneering science to create transformative molecular medicines. | Asklepios BioPharmaceutical, Inc. (AskBio), a โฆSee details»
Inside the $4B AskBio deal, the third largest buyout ever for an NC ...
Oct 27, 2020 Bayer will own AskBioโs gene therapy platform, including a broad intellectual property portfolio and a contract development and manufacturing organization based on โฆSee details»
First Patient Randomized in AskBio Phase II Gene Therapy Trial for ...
Feb 16, 2024 BERLIN & RESEARCH TRIANGLE PARK, N.C., February 16, 2024--Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and โฆSee details»
Asklepios BioPharmaceutical, Inc. (AskBio): Culture | LinkedIn
Asklepios BioPharmaceutical, Inc. (AskBio) | 36,647 followers on LinkedIn. Pioneering science to create transformative molecular medicines. | Asklepios BioPharmaceutical, Inc. (AskBio), a โฆSee details»
Bayer Acquires AskBio to Broaden Innovation Base in Cell and โฆ
Oct 26, 2020 As a result of the acquisition, Bayer will own AskBioโs gene therapy platform, including a broad intellectual property portfolio and established contract development and โฆSee details»
Bayer buys cell & gene therapy firm AskBio for $4 billion
Oct 26, 2020 Bayer is making clear its ambitions in cell and gene therapy with a $4 billion acquisition of US biotech Asklepios BioPharmaceutical, also known as AskBio. AskBioโs โฆSee details»
First patient randomized in AskBio Phase II gene therapy trial for ...
Feb 16, 2024 About AskBio Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company โฆSee details»
How 2 scientific pioneers teamed up to run AskBio, Bayer's new โฆ
Jan 21, 2021 At AskBio, she's been named president of therapeutics. The role, however, lines up with High's current career ambitions. AskBio has the manufacturing capabilities, breadth of โฆSee details»
AskBio Announces 11 Presentations at the American Society of โฆ
May 11, 2023 Viralgen, an independently operated Contract Development and Manufacturing Organization (CDMO), was founded in 2017 as a joint venture between AskBio and Columbus โฆSee details»
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug โฆ
Nov 7, 2024 Research Triangle Park, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment โฆSee details»
Pioneers in Gene Therapy - Leadership Team - AskBio
The AskBio Team. The AskBio team is comprised of some of the most accomplished and experienced genetic researchers, clinicians and biopharmaceutical industry veterans. Our โฆSee details»
AskBio Announces 11 Presentations at the European Society
Oct 17, 2024 Viralgen is a fully integrated contract development and manufacturing organization (CDMO) founded in 2017 as an independently operated subsidiary of Asklepios โฆSee details»
Corporate Support & Charitable Contribution Guidelines - AskBio
AskBio will review charitable requests from U.S. nonprofit organizations described in Sections 501(c)(3) and 509 (a)(1)(2)(3) of the U.S. Internal Revenue Code including: ... Letter of โฆSee details»
Gene Therapy Patient Advocacy & Information | AskBio
Email us at [email protected]. Facebook; LinkedIn; Twitter; YouTube; Inquiries. Media Center; Contact Us; Careers; Corporate Support; US Headquarters. 20 T.W. Alexander Drive โฆSee details»